• Home
  •  / Hummingbird

Hummingbird

OverviewSuggest Edit

Hummingbird is a platform for managing anti-money laundering (AML) operations. It reduces cumbersome paperwork, provides insightful analytics, and enables collaboration for compliance professionals and law enforcement agents.

TypePrivate
Founded2016
HQWalnut, CA, USMap
Websitehummingbird.co

Recent NewsAll News

Latest Updates

Employees (est.) (Nov 2020)17(+7%)
Cybersecurity ratingAMore

Key People/Management at Hummingbird

Jo Ann Barefoot

Jo Ann Barefoot

Co-Founder, Board
Matt van Buskirk

Matt van Buskirk

Co-CEO, Regulatory
Joe Robinson

Joe Robinson

Co-CEO, Product & Operations
Show more

Hummingbird Office Locations

Hummingbird has an office in Walnut
Walnut, CA, US (HQ)
340 S Lemon Ave #4151
Show all (1)

Hummingbird Financials and Metrics

Summary Metrics

Founding Date

2016

Hummingbird total Funding

$11.2 m

Hummingbird latest funding size

$8.20 m

Time since last funding

6 months ago

Hummingbird investors

Homebrew, TTV Capital, Omidyar Network, Designer Fund, Lachy Groom, Flourish Ventures, Jon Zieger, Hombrew
Hummingbird's latest funding round in July 2020 was reported to be $8.2 m. In total, Hummingbird has raised $11.2 m
Show all financial metrics

Hummingbird Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

Learn more about our premium products
SecurityScorecard logo

Hummingbird Online and Social Media Presence

Hummingbird's Trends

Embed Graph

Hummingbird News and Updates

January 09, 2020

Hummingbird – AirVPN's free and open source OpenVPN 3 client

Comments
December 16, 2019

IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care

STOCKHOLM, Dec. 16, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the launch of its Hummingbird® ICP Monitoring product family in the United States. These products, which were acquired...
December 06, 2019

Singapore healthtech startup Hummingbird banks $19m in series B round

It plans to use the new funds to discover new disease targets, expand its pipeline of antibody therapeutics, and fuel collaboration efforts.
December 05, 2019

Hummingbird Bioscience secures $19m in Mirae Asset-backed Series B

The firm focuses on the discovery and development of novel antibody-based therapeutics. The post Hummingbird Bioscience secures $19m in Mirae Asset-backed Series B appeared first on DealStreetAsia.
December 05, 2019

Hummingbird Bioscience Raises US$19 Million in Series B Financing

SINGAPORE, Dec. 4, 2019 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision antibody therapeutics for difficult-to-treat conditions, today announced that it has raised US$19 million in a...
October 11, 2019

Teekay Corporation Announces 3.5-Year Contract for the Hummingbird Spirit FPSO

VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Teekay Corporation (Teekay or the Company) (NYSE:TK) announced that it has entered into an agreement with the Chestnut Joint Venture, a joint venture between Spirit Energy Ltd. and Dana Petroleum Ltd., to extend the employment of the H…
Show more

 Hummingbird Frequently Asked Questions

  • When was Hummingbird founded?

    Hummingbird was founded in 2016.

  • Who are Hummingbird key executives?

    Hummingbird's key executives are Jo Ann Barefoot, Matt van Buskirk and Joe Robinson.

  • How many employees does Hummingbird have?

    Hummingbird has 17 employees.

  • Who are Hummingbird competitors?

    Competitors of Hummingbird include Crediteo, Darwin Automotive and Electronic IDentification.

  • Where is Hummingbird headquarters?

    Hummingbird headquarters is located at 340 S Lemon Ave #4151, Walnut.

  • Where are Hummingbird offices?

    Hummingbird has an office in Walnut.

  • How many offices does Hummingbird have?

    Hummingbird has 1 office.